Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Feb;33(2):131–135. doi: 10.1128/aac.33.2.131

Structure-activity relationships of the fluoroquinolones.

D T Chu 1, P B Fernandes 1
PMCID: PMC171443  PMID: 2655528

Full text

PDF
135

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agui H., Mitani T., Izawa A., Komatsu T., Nakagome T. Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. J Med Chem. 1977 Jun;20(6):791–796. doi: 10.1021/jm00216a010. [DOI] [PubMed] [Google Scholar]
  2. Albrecht R. Development of antibacterial agents of the nalidixic acid type. Prog Drug Res. 1977;21:9–104. doi: 10.1007/978-3-0348-7098-6_1. [DOI] [PubMed] [Google Scholar]
  3. Benbrook D. M., Miller R. V. Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1986 Jan;29(1):1–6. doi: 10.1128/aac.29.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bowie W. R., Shaw C. E., Chan D. G., Boyd J., Black W. A. In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens. Antimicrob Agents Chemother. 1986 Oct;30(4):590–593. doi: 10.1128/aac.30.4.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chin N. X., Brittain D. C., Neu H. C. In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone. Antimicrob Agents Chemother. 1986 Apr;29(4):675–680. doi: 10.1128/aac.29.4.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chu D. T., Fernandes P. B., Claiborne A. K., Pihuleac E., Nordeen C. W., Maleczka R. E., Jr, Pernet A. G. Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents. J Med Chem. 1985 Nov;28(11):1558–1564. doi: 10.1021/jm00149a003. [DOI] [PubMed] [Google Scholar]
  7. Chu D. T., Fernandes P. B., Pernet A. G. Synthesis and biological activity of benzothiazolo[3,2-a]quinolone antibacterial agents. J Med Chem. 1986 Aug;29(8):1531–1534. doi: 10.1021/jm00158a037. [DOI] [PubMed] [Google Scholar]
  8. Cozzarelli N. R. DNA gyrase and the supercoiling of DNA. Science. 1980 Feb 29;207(4434):953–960. doi: 10.1126/science.6243420. [DOI] [PubMed] [Google Scholar]
  9. Culbertson T. P., Domagala J. M., Nichols J. B., Priebe S., Skeean R. W. Enantiomers of 1-ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid: preparation and biological activity. J Med Chem. 1987 Oct;30(10):1711–1715. doi: 10.1021/jm00393a004. [DOI] [PubMed] [Google Scholar]
  10. Domagala J. M., Hagen S. E., Heifetz C. L., Hutt M. P., Mich T. F., Sanchez J. P., Trehan A. K. 7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials. J Med Chem. 1988 Mar;31(3):503–506. doi: 10.1021/jm00398a003. [DOI] [PubMed] [Google Scholar]
  11. Domagala J. M., Hanna L. D., Heifetz C. L., Hutt M. P., Mich T. F., Sanchez J. P., Solomon M. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J Med Chem. 1986 Mar;29(3):394–404. doi: 10.1021/jm00153a015. [DOI] [PubMed] [Google Scholar]
  12. Domagala J. M., Heifetz C. L., Hutt M. P., Mich T. F., Nichols J. B., Solomon M., Worth D. F. 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials. J Med Chem. 1988 May;31(5):991–1001. doi: 10.1021/jm00400a017. [DOI] [PubMed] [Google Scholar]
  13. Egawa H., Miyamoto T., Matsumoto J. A new synthesis of 7H-pyrido[1,2,3-de][1,4]benzoxazine derivatives including an antibacterial agent, ofloxacin. Chem Pharm Bull (Tokyo) 1986 Oct;34(10):4098–4102. doi: 10.1248/cpb.34.4098. [DOI] [PubMed] [Google Scholar]
  14. Fernandes P. B., Shipkowitz N., Bower R. R., Jarvis K. P., Weisz J., Chu D. T. In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria. J Antimicrob Chemother. 1986 Dec;18(6):693–701. doi: 10.1093/jac/18.6.693. [DOI] [PubMed] [Google Scholar]
  15. Gargallo D., Moros M., Coll R., Esteve M., Parés J., Xicota M. A., Guinea J. Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats. Antimicrob Agents Chemother. 1988 May;32(5):636–641. doi: 10.1128/aac.32.5.636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gellert M., Mizuuchi K., O'Dea M. H., Itoh T., Tomizawa J. I. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci U S A. 1977 Nov;74(11):4772–4776. doi: 10.1073/pnas.74.11.4772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Georgopapadakou N. H., Dix B. A., Angehrn P., Wick A., Olson G. L. Monocyclic and tricyclic analogs of quinolones: mechanism of action. Antimicrob Agents Chemother. 1987 Apr;31(4):614–616. doi: 10.1128/aac.31.4.614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gerster J. F., Rohlfing S. R., Pecore S. E., Winandy R. M., Stern R. M., Landmesser J. E., Olsen R. A., Gleason W. B. Synthesis, absolute configuration, and antibacterial activity of 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H- benzo[ij]quinolizine-2-carboxylic acid. J Med Chem. 1987 May;30(5):839–843. doi: 10.1021/jm00388a016. [DOI] [PubMed] [Google Scholar]
  19. Goueffon Y., Montay G., Roquet F., Pesson M. Sur un nouvel antibactérien de synthèse : l'acide éthyl-1 fluoro-6 (méthyl-4 pipérazinyl-1)-7 oxo-4 dihydro-1.4 quinoléine-3 carboxylique (1589 R.B.). C R Seances Acad Sci III. 1981 Jan 5;292(1):37–40. [PubMed] [Google Scholar]
  20. Granneman G. R., Snyder K. M., Shu V. S. Difloxacin metabolism and pharmacokinetics in humans after single oral doses. Antimicrob Agents Chemother. 1986 Nov;30(5):689–693. doi: 10.1128/aac.30.5.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hardy D. J., Swanson R. N., Hensey D. M., Ramer N. R., Bower R. R., Hanson C. W., Chu D. T., Fernandes P. B. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones. Antimicrob Agents Chemother. 1987 Nov;31(11):1768–1774. doi: 10.1128/aac.31.11.1768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hirai K., Aoyama H., Suzue S., Irikura T., Iyobe S., Mitsuhashi S. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother. 1986 Aug;30(2):248–253. doi: 10.1128/aac.30.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hirai K., Suzue S., Irikura T., Iyobe S., Mitsuhashi S. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1987 Apr;31(4):582–586. doi: 10.1128/aac.31.4.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hooper D. C., Wolfson J. S., Souza K. S., Tung C., McHugh G. L., Swartz M. N. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrob Agents Chemother. 1986 Apr;29(4):639–644. doi: 10.1128/aac.29.4.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. International Symposium on New Quinolones. Geneva, Switzerland, July 17-19, 1986. Proceedings. Rev Infect Dis. 1988 Jan-Feb;10 (Suppl 1):S1–271. [PubMed] [Google Scholar]
  26. International Symposium on New Quinolones. Geneva, Switzerland, July 17-19, 1986. Proceedings. Rev Infect Dis. 1988 Jan-Feb;10 (Suppl 1):S1–271. [PubMed] [Google Scholar]
  27. Jack D. B. Recent advances in pharmaceutical chemistry. The 4-quinolone antibiotics. J Clin Hosp Pharm. 1986 Apr;11(2):75–93. doi: 10.1111/j.1365-2710.1986.tb00831.x. [DOI] [PubMed] [Google Scholar]
  28. Klopman G., Macina O. T., Levinson M. E., Rosenkranz H. S. Computer automated structure evaluation of quinolone antibacterial agents. Antimicrob Agents Chemother. 1987 Nov;31(11):1831–1840. doi: 10.1128/aac.31.11.1831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Koga H., Itoh A., Murayama S., Suzue S., Irikura T. Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. J Med Chem. 1980 Dec;23(12):1358–1363. doi: 10.1021/jm00186a014. [DOI] [PubMed] [Google Scholar]
  30. Kondo H., Sakamoto F., Kawakami K., Tsukamoto G. Studies on prodrugs. 7. Synthesis and antimicrobial activity of 3-formylquinolone derivatives. J Med Chem. 1988 Jan;31(1):221–225. doi: 10.1021/jm00396a035. [DOI] [PubMed] [Google Scholar]
  31. Mitscher L. A., Sharma P. N., Chu D. T., Shen L. L., Pernet A. G. Chiral DNA gyrase inhibitors. 1. Synthesis and antimicrobial activity of the enantiomers of 6-fluoro-7-(1-piperazinyl)-1-(2'-trans-phenyl-1'-cyclopropyl)-1, 4-dihydro-4-oxoquinoline-3-carboxylic acid. J Med Chem. 1986 Oct;29(10):2044–2047. doi: 10.1021/jm00160a042. [DOI] [PubMed] [Google Scholar]
  32. Mitscher L. A., Sharma P. N., Chu D. T., Shen L. L., Pernet A. G. Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H- pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin). J Med Chem. 1987 Dec;30(12):2283–2286. doi: 10.1021/jm00395a017. [DOI] [PubMed] [Google Scholar]
  33. Robillard N. J., Scarpa A. L. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother. 1988 Apr;32(4):535–539. doi: 10.1128/aac.32.4.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sato K., Matsuura Y., Inoue M., Une T., Osada Y., Ogawa H., Mitsuhashi S. In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother. 1982 Oct;22(4):548–553. doi: 10.1128/aac.22.4.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sugino A., Peebles C. L., Kreuzer K. N., Cozzarelli N. R. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci U S A. 1977 Nov;74(11):4767–4771. doi: 10.1073/pnas.74.11.4767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Verbist L. Quinolones: pharmacology. Pharm Weekbl Sci. 1986 Feb 21;8(1):22–25. doi: 10.1007/BF01975474. [DOI] [PubMed] [Google Scholar]
  37. Wentland M. P., Bailey D. M., Cornett J. B., Dobson R. A., Powles R. G., Wagner R. B. Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships. J Med Chem. 1984 Sep;27(9):1103–1108. doi: 10.1021/jm00375a003. [DOI] [PubMed] [Google Scholar]
  38. Wise R., Andrews J. M., Edwards L. J. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother. 1983 Apr;23(4):559–564. doi: 10.1128/aac.23.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wolfson J. S., Hooper D. C., Ng E. Y., Souza K. S., McHugh G. L., Swartz M. N. Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers. Antimicrob Agents Chemother. 1987 Nov;31(11):1861–1863. doi: 10.1128/aac.31.11.1861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yanagisawa H., Nakao H., Ando A. Studies on chemotherapeutic agents. I. Synthesis of quinoline and naphthyridine sulfonamide or phosphonic acid derivatives. Chem Pharm Bull (Tokyo) 1973 May;21(5):1080–1089. doi: 10.1248/cpb.21.1080. [DOI] [PubMed] [Google Scholar]
  41. Zweerink M. M., Edison A. Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids. Antimicrob Agents Chemother. 1986 Apr;29(4):598–601. doi: 10.1128/aac.29.4.598. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES